Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Surgalign Holdings, Inc. (SRGAQ) had Revenue of $81.98M for the most recently reported fiscal year, ending 2022-12-31.

Quarterly Annual

Figures for fiscal year ending 2022-12-31

Income Statement Financials
Revenue	$81.98M
Net Income	$-54.60M
Cost of Goods Sold	$41.69M
Gross Profit	$40.29M
Operating Expenses	$160.44M
Operating Income	$-78.46M
Non-Operating Income/Expense	$22.81M
Pre-Tax Income	$-55.65M
Normalized Pre-Tax Income	$-55.65M
Income after Taxes	$-54.60M
Income from Continuous Operations	$-54.60M
Consolidated Net Income/Loss	$-54.60M
Normalized Income after Taxes	$-54.60M
EBIT	$-78.46M
EBITDA	$-76.28M
Weighted-Average Shares Outstanding (Basic)	6.56M
Weighted-Average Shares Outstanding (Diluted)	6.56M
Earnings per Share (EPS) (Basic)	$-8.33
Earnings per Share (EPS) (Diluted)	$-8.33
Balance Sheet Financials
Current Assets	$56.71M
Property, Plant, and Equipment	$2.06M
Long-Term Assets	$13.53M
Total Assets	$70.24M
Current Liabilities	$21.15M
Long-Term Debt	$10.19M
Long-Term Liabilities	$74.82M
Total Liabilities	$95.97M
Common Equity	$-25.73M
Tangible Shareholders Equity	$-25.73M
Shareholders Equity	$-25.73M
Common Shares Outstanding	7.86M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-52.11M
Cash Flow from Investing Activities	$-7.26M
Cash Flow from Financial Activities	$24.66M
Beginning Cash	$51.29M
End Cash	$16.30M
Increase/Decrease in Cash	$-34.99M
Stock-Based Compensation	$4.63M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.68
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	-0.66
Debt to Equity Ratio	-0.40
Gross Margin	49.14%
Operating Margin	-95.71%
EBIT Margin	-95.71%
EBITDA Margin	-93.05%
Pre-Tax Profit Margin	-67.88%
Profit Margin	-66.61%
Free Cash Flow	$-58.89M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.17
Inventory Turnover	2.35
Receiveable Turnover	5.11
Days Sales in Receivables	71.49
Return on Equity	212.23%
Return on Tangible Equity	212.23%
Return on Assets	-77.74%
Return on Investments	351.45%
Book Value Per Share	$-3.27
Free Cash Flow per Share	$-8.98
Operating Cash Flow per Share	$-7.95

Data from Zacks Investment Research, Inc.